Mahmoud Aghaei

20PUBLICATIONS
30CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedCharacterisation of biological macromoleculesMolecular targetsPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 13, 2025
Correction: Aghaei et al. The Role of BiP and the IRE1α-XBP1 Axis in Rhabdomyosarcoma Pathology. Cancers 2021, 13, 4927.

Mahmoud Aghaei, Ahmad Nasimian, Marveh Rahmati

|Mar 11, 2025
Malleatin A and B: New Premyrsine-Type Diterpenes from Euphorbia malleata with Cytotoxic Effects Against A2780 Wild and A2780 R-CIS Ovarian Cancer Cell Lines in Mono or Combination Treatment with Cisplatin.

Behzad Zolfaghari, Forough Akbari, Sajad Esmaeili

|Mar 16, 2023
VEGFR3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer via ERK1/2 and AKT signaling pathways.

Zeinab Babaei, Mojtaba Panjehpour, Seyedeh Sara Ghorbanhosseini

|Feb 07, 2023
Molecular mechanisms of miR-1236 in the assessment of tumor lymphangiogenesis in human ovarian cancer patients.

Mahsa Khademi, Zeinab Babaei, Seyedeh Sara Ghorbanhosseini

|Sep 05, 2022
New Cytotoxic Premyrsinane-Type Diterpenes from Euphorbia aleppica Against Breast Cancer Cells.

Behzad Zolfaghari, Ali Farahani, Amin Jannesari

|Jan 22, 2022
Beneficial effects of MgSO4 on TFAM, UPC3 and FNDC5 mRNA expressions in skeletal muscle of type 2 diabetic rats: a possible mechanism to improve insulin resistance.

Farzaneh Yazdanimoghaddam, Mahmoud Aghaei, Maedeh Ghasemi

Pageof 4

Frequent Collaborators

3 joint publications

Mustafa Ghanadian

3 joint publications

Saeid Ghavami

2 joint publications

Mojtaba Panjehpour

2 joint publications

Afshin Samali